Phibro Animal Health Reports Q1 2027 Revenue Growth Driven by Mineral Nutrition and Performance Products
Phibro Animal Health Corporation (PAHC) reported its first quarter fiscal 2027 results, highlighted by a 6% year-over-year revenue increase to $386.8 million. The growth was primarily fueled by strong performance in the Mineral Nutrition and Performance Products segments, which saw double-digit increases due to rising average selling prices and higher demand for copper and zinc products. Net income rose 11% to $29.5 million, benefiting from favorable foreign currency exchange rates and reduced interest costs. While Animal Health sales grew by 3%, certain sub-sectors like Nutritional Specialties and Vaccines faced headwinds due to softer poultry demand in North America and regulatory shifts in Brazil. The company provided optimistic full-year guidance for fiscal 2027, projecting adjusted diluted EPS growth of approximately 9% at the midpoint.
Topics: animal health mineral nutrition net income increase revenue growth segment performance